ULTRAGENYX PHARMACEUTICAL INC. - COMMON STOCK

Ultragenyx to Present at Piper Sandler Healthcare Conference

22 ноя 2022 16:01:00 Источник Nasdaq GlobeNewswire

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

18 ноя 2022 16:05:00 Источник Nasdaq GlobeNewswire

Ultragenyx Announces Departure of Chief Financial Officer

10 ноя 2022 16:15:00 Источник Nasdaq GlobeNewswire

Ultragenyx to Present at Upcoming Healthcare Conferences

09 ноя 2022 16:01:00 Источник Nasdaq GlobeNewswire

Ultragenyx Reports Third Quarter 2022 Financial Results and Corporate Update

02 ноя 2022 16:05:01 Источник Nasdaq GlobeNewswire

Ultragenyx to Host Conference Call for Third Quarter 2022 Financial Results and Corporate Update

27 окт 2022 16:01:00 Источник Nasdaq GlobeNewswire

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

04 окт 2022 16:30:00 Источник Nasdaq GlobeNewswire

Ultragenyx and Mereo BioPharma to Present Setrusumab Data Update at ASBMR

09 сен 2022 20:22:15 Источник Nasdaq GlobeNewswire

Ultragenyx to Participate at Citi BioPharma Conference

01 сен 2022 16:01:00 Источник Nasdaq GlobeNewswire

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

17 авг 2022 16:01:00 Источник Nasdaq GlobeNewswire

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

03 авг 2022 16:05:02 Источник Nasdaq GlobeNewswire

Ultragenyx Reports Second Quarter 2022 Financial Results and Corporate Update

28 июл 2022 16:01:00 Источник Nasdaq GlobeNewswire

Ultragenyx to Host Conference Call for Second Quarter 2022 Financial Results and Corporate Update

25 июл 2022 16:01:00 Источник Nasdaq GlobeNewswire

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

20 июл 2022 17:09:15 Источник Nasdaq GlobeNewswire

Ultragenyx and GeneTx Provide Program Update on GTX-102 for Angelman Syndrome Including Promising Interim Data from Phase 1/2 Study

18 июл 2022 16:00:00 Источник Nasdaq GlobeNewswire

Ultragenyx Announces Sale of a Portion of Future North American Royalties on Crysvita® (burosumab) for $500 Million to OMERS Capital Markets

14 июл 2022 08:30:00 Источник Nasdaq GlobeNewswire

Ultragenyx to Present at Goldman Sachs Global Healthcare Conference

10 июн 2022 08:00:00 Источник Nasdaq GlobeNewswire

Ultragenyx to Present at Jefferies Global Healthcare Conference

01 июн 2022 16:01:00 Источник Nasdaq GlobeNewswire

Ultragenyx Announces Positive Longer-term Durability Data from Two Phase 1/2 Gene Therapy Studies at American Society of Gene & Cell Therapy (ASGCT) 2022 Annual Meeting

19 май 2022 08:00:01 Источник Nasdaq GlobeNewswire

Ultragenyx Acquires Global Rights to AAV Gene Therapy ABO-102 for Sanfilippo Syndrome Type A (MPS IIIA) from Abeona Therapeutics

17 май 2022 08:00:02 Источник Nasdaq GlobeNewswire